688356.SH
键凯科技
SSE · Healthcare · Medical - Pharmaceuticals · CN
CNY 124.00
+15.52%Year over year
Reported trailing growth
- Revenue
- +41.9%
- EBITDA
- —
- EBIT
- +177.2%
- EPS
- +162.3%
- Free cash flow
- +6.0%
- Operating cash flow
- +101.6%
Forward estimates
Based on analyst estimates
- Revenue
- -49.7%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -7.9%
- EBITDA
- -21.1%
- EBIT
- -30.6%
- Net income
- -30.9%
- EPS
- -31.0%
- Free cash flow
- -19.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026